JPS62221402A - 中空繊維状分離膜の製造方法 - Google Patents
中空繊維状分離膜の製造方法Info
- Publication number
- JPS62221402A JPS62221402A JP6421986A JP6421986A JPS62221402A JP S62221402 A JPS62221402 A JP S62221402A JP 6421986 A JP6421986 A JP 6421986A JP 6421986 A JP6421986 A JP 6421986A JP S62221402 A JPS62221402 A JP S62221402A
- Authority
- JP
- Japan
- Prior art keywords
- blood
- polysulfone
- solvent
- membrane
- separation membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 32
- 238000000926 separation method Methods 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 238000009987 spinning Methods 0.000 claims abstract description 22
- 239000002904 solvent Substances 0.000 claims abstract description 15
- 229920002492 poly(sulfone) Polymers 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 6
- 238000002166 wet spinning Methods 0.000 claims abstract description 3
- 239000004695 Polyether sulfone Substances 0.000 claims abstract 5
- 229920006393 polyether sulfone Polymers 0.000 claims abstract 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000005345 coagulation Methods 0.000 claims description 9
- 230000015271 coagulation Effects 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 7
- 239000011347 resin Substances 0.000 claims description 7
- 229920005989 resin Polymers 0.000 claims description 7
- 239000011550 stock solution Substances 0.000 claims description 7
- 239000012510 hollow fiber Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 230000001112 coagulating effect Effects 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 2
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 23
- 230000001105 regulatory effect Effects 0.000 abstract 2
- 238000001914 filtration Methods 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 238000002615 hemofiltration Methods 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 7
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 6
- 150000003457 sulfones Chemical class 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000001631 haemodialysis Methods 0.000 description 5
- 230000000322 hemodialysis Effects 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 208000009304 Acute Kidney Injury Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000033626 Renal failure acute Diseases 0.000 description 3
- 201000011040 acute kidney failure Diseases 0.000 description 3
- 208000012998 acute renal failure Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000020832 chronic kidney disease Diseases 0.000 description 3
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- -1 ether sulfone Chemical class 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- 239000011475 Accrington brick Substances 0.000 description 1
- 229930091051 Arenine Natural products 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000000365 Oenanthe javanica Nutrition 0.000 description 1
- 240000008881 Oenanthe javanica Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 241000206608 Pyropia tenera Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910001622 calcium bromide Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000007380 fibre production Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6421986A JPS62221402A (ja) | 1986-03-24 | 1986-03-24 | 中空繊維状分離膜の製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6421986A JPS62221402A (ja) | 1986-03-24 | 1986-03-24 | 中空繊維状分離膜の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62221402A true JPS62221402A (ja) | 1987-09-29 |
| JPH0563214B2 JPH0563214B2 (enrdf_load_stackoverflow) | 1993-09-10 |
Family
ID=13251767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6421986A Granted JPS62221402A (ja) | 1986-03-24 | 1986-03-24 | 中空繊維状分離膜の製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62221402A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6284137B1 (en) | 1994-06-07 | 2001-09-04 | Mitsubishi Rayon Co., Ltd. | Polysulfone porous membrane and a method of manufacturing the same |
| CN1076630C (zh) * | 1997-12-17 | 2001-12-26 | 四川联合大学 | 聚醚砜中空纤维膜及其制造方法和用途 |
-
1986
- 1986-03-24 JP JP6421986A patent/JPS62221402A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6284137B1 (en) | 1994-06-07 | 2001-09-04 | Mitsubishi Rayon Co., Ltd. | Polysulfone porous membrane and a method of manufacturing the same |
| CN1076630C (zh) * | 1997-12-17 | 2001-12-26 | 四川联合大学 | 聚醚砜中空纤维膜及其制造方法和用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0563214B2 (enrdf_load_stackoverflow) | 1993-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4874522A (en) | Polysulfone hollow fiber membrane and process for making the same | |
| WO1997034687A1 (fr) | Membrane en fils creux utilisee pour l'epuration du sang et epurateur de sang | |
| US5736046A (en) | High-flux hollow-fiber membrane with enhanced transport capability and process for making same | |
| WO2000072950A1 (fr) | Membrane à fibres creuses issue de dérivés de cellulose | |
| JP3934340B2 (ja) | 血液浄化器 | |
| JPH053335B2 (enrdf_load_stackoverflow) | ||
| JPS62221402A (ja) | 中空繊維状分離膜の製造方法 | |
| JP2703266B2 (ja) | ポリスルホン中空繊維膜およびその製法 | |
| JP7261328B2 (ja) | チューブラー型分離膜とそれを含むチューブラー型分離膜モジュール | |
| JP4103037B2 (ja) | 透析液清浄化用中空糸膜およびその製造方法 | |
| JP4493097B2 (ja) | 持続式血液濾過装置 | |
| WO2016182015A1 (ja) | 多孔質中空糸膜及びその製造方法 | |
| JP3424810B2 (ja) | 高性能血液浄化膜 | |
| JPS62121608A (ja) | 血液浄化用中空糸膜の製造方法 | |
| JP3241855B2 (ja) | 無機塩で目詰めされた多孔膜 | |
| JPH0211263B2 (enrdf_load_stackoverflow) | ||
| JPS61113458A (ja) | 血液浄化器 | |
| JP2000210544A (ja) | 半透膜の製造方法 | |
| JP4164730B2 (ja) | 選択分離膜 | |
| KR930003740B1 (ko) | 폴리설폰 중공사 분리막의 제조방법 | |
| JPS61113460A (ja) | 血液清浄化用中空糸膜 | |
| JPS61293502A (ja) | 血液浄化用分離膜 | |
| JPH09308684A (ja) | 選択分離膜 | |
| JPH07148252A (ja) | 血液浄化用中空糸膜 | |
| JPS59209611A (ja) | 中空糸状膜及びその製造方法 |